The top 10 med-tech stock gainers and losers for the week.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Chromocell, Channel, Eyenovia, Evotec, Halozyme, Lexicon, Protagonist.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Akeso, GSK, Johnson, Leads, Merck, Replimune.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Ascentage, Immune-onc.

Biopharmas raising money in public or private financings, including: Aptose, Autoimmunity, Biofrontera, Bioxcel, Enveda, Oncoverity.

New hires and promotions in the biopharma industry, including: Cytodyn, Preveceutical.

The top 10 biopharma stock gainers and losers for the week.

New hires and promotions in the med-tech industry, including: Medline, Onecell

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Humacyte.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abbott, Boston Scientific, Briohealth Solutions, Illumina, Intera Oncology, Insulet, Myriad Genetics, RTI Surgical, Virtual Incision.